Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kral, J; Nakov, R; Lanska, V; Barberio, B; Benech, N; Blesl, A; Brunet, E; Capela, T; Derikx, L; Dragoni, G; Eek, A; Frias-Gomes, C; Gîlcă-Blanariu, GE; Gilroy, L; Harvey, P; Kagramanova, A; Kani, HT; Konikoff, T; Lessing, M; Madsen, G; Maksimaityte, V; Miasnikova, M; Mikolasevic, I; Milivojevic, V; Noviello, D; Oliinyk, D; Patai, A; Pisani, A; Protopapas, A; Rodríguez-Lago, I; Schreiner, P; Skuja, V; Tran, F; Truyens, M; Włodarczyk, M; Zatorski, H; Verstockt, B; Segal, JP.
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
Dig Dis. 2023; 41(3):387-395
Doi: 10.1159/000528070
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Blesl Andreas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries. METHODS: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank). RESULTS: The online survey was completed by 1,285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%), were observed between respondees from high and low GDP countries (p < 0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p < 0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p < 0.0001). In the current COVID era, telemedicine is available in 73.2% versus 54.1% of the high/low GDP countries, respectively (p < 0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly. CONCLUSION: Much variability in IBD practice exists across Europe, with marked differences between high and low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- COVID-19 - administration & dosage
- Inflammatory Bowel Diseases - epidemiology, therapy
- Europe - epidemiology
- Surveys and Questionnaires - administration & dosage
- Biological Products - administration & dosage
- Find related publications in this database (Keywords)
- Inflammatory bowel diseases
- Quality of care
- Training
- VIPER
- European